NOEVIR HOLDINGS CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,430 JPY | +0.37% |
|
+1.69% | +5.64% |
| Sales 2024 * | 63.4B 403M | Sales 2025 * | 65.15B 414M | Capitalization | 185B 1.18B |
|---|---|---|---|---|---|
| Net income 2024 * | 7.9B 50.19M | Net income 2025 * | 8.15B 51.78M | EV / Sales 2024 * | 2.93 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.85 x |
| P/E ratio 2024 * |
23.5
x | P/E ratio 2025 * |
22.8
x | Employees | 1,368 |
| Yield 2024 * |
4.14% | Yield 2025 * |
4.24% | Free-Float | 47.61% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.37% | ||
| 1 week | +1.69% | ||
| 1 month | +4.02% | ||
| 3 months | +4.02% | ||
| 6 months | +4.02% | ||
| Current year | +5.64% |
1 week
5 280.00
5 460.00
1 month
5 160.005 460.00
Current year
5 080.005 460.00
1 year
4 985.005 770.00
3 years
4 880.006 140.00
5 years
3 985.006 330.00
10 years
1 892.009 170.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yasuo Kaiden
PSD | President | 68 | 11-03-21 |
Mitsuyoshi Hanyu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director/Board Member | - | Nov. 27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hiroshi Okura
CHM | Chairman | 87 | 11-03-21 |
Ikkou Yoshida
BRD | Director/Board Member | 67 | 11-03-21 |
Yasuo Kaiden
PSD | President | 68 | 11-03-21 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.26% | 10 M€ | +8.05% | ||
| 0.04% | 4 M€ | +19.76% | ||
| 0.02% | 17 M€ | +14.54% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 5,430 | +0.37% | 37,000 |
| 24-05-30 | 5,410 | +2.08% | 52,500 |
| 24-05-29 | 5,300 | -0.56% | 19,800 |
| 24-05-28 | 5,330 | -0.37% | 15,500 |
| 24-05-27 | 5,350 | +0.19% | 15,500 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotes
Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.
Sector
Personal Products
Calendar
2024-07-29
- Q3 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
5,430
JPY
Average target price
5,730
JPY
Spread / Average Target
+5.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.64% | 1.18B | |
| +0.32% | 262B | |
| +18.76% | 20.37B | |
| -.--% | 19.29B | |
| +16.91% | 12.64B | |
| -16.59% | 8.94B | |
| +33.93% | 8.62B | |
| +9.55% | 5.93B | |
| -12.08% | 3.92B | |
| -16.83% | 3.84B |
- Stock Market
- Equities
- 4928 Stock
